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How long people live depends on their health, and how it changes with age. Individual health can
be tracked by the accumulation of age-related health deficits. The fraction of age-related deficits
is a simple quantitative measure of human aging. This quantitative frailty index (F ) is as good
as chronological age in predicting mortality. In this paper, we use a dynamical network model of
deficits to explore the effects of interactions between deficits, deficit damage and repair processes,
and the connection between the F and mortality. With our model, we qualitatively reproduce
Gompertz’s law of increasing human mortality with age, the broadening of the F distribution with
age, the characteristic non-linear increase of the F with age, and the increased mortality of high-
frailty individuals. No explicit time-dependence in damage or repair rates is needed in our model.
Instead, implicit time-dependence arises through deficit interactions – so that the average deficit
damage rates increases, and deficit repair rates decreases, with age . We use a simple mortality
criterion, where mortality occurs when the most connected node is damaged.
PACS numbers: 87.10.Mn, 87.10.Rt, 87.10.Vg, 87.18.-h
I. INTRODUCTION
Average human mortality rates increase exponentially
with age, following Gompertz’s law [1]. This exponential
growth holds well for ages between 40 and 100 years, and
possibly older [2]. Individual mortality is preceded by
the dynamical process of aging, which can be viewed as
the accumulation of organismal damage with time [3].
Because individuals can accumulate health problems at
different times, the health status of populations of a given
age is heterogeneous. Individual “frailty” could account
for at least some of the differences in mortality rates for
individuals of the same age [17], where frailty results from
the individual accumulation of damage during aging.
One quantitative measure of frailty is the time-
dependent “frailty index” (FI) [4–9], quantitatively de-
noted F . Clinically, the frailty index is assessed by scor-
ing a broad portfolio of possible age-related deficits as
either 0 (healthy) or 1 (damaged). Then F is the pro-
portion that are damaged, and ranges from 0 for per-
fectly healthy individuals to a theoretical maximum of 1
[5]. Remarkably, in elderly populations the frailty index
is as predictive as chronological age for various health-
outcomes – including mortality [9–11]. Many different
portfolios of age-related deficits, of different sizes, have
similar behavior [12, 13]. For example, an FI can be cre-
ated from biomarkers and laboratory tests [14]. An FI
can also be calculated for mice, and shows similar behav-
ior as for humans [15]. Nevertheless, our understanding
of frailty accumulation in individuals remains largely em-
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pirical [6].
The distribution of the frailty index broadens signifi-
cantly with age [13, 16]. This indicates that the stochas-
ticity of frailty dynamics is significant [17, 18]. Indeed,
longitudinal studies show both increases and decreases
of F with increasing age of individuals [19–21], and there
are also direct indications that at least some individual
deficits are reversible [7, 19, 22]. Two additional obser-
vations focus our approach. First, the time-dependent
average F (t) shows a significant upward curvature vs.
age [4, 6, 11–13, 23, 24]. While linear accumulation of
deficits with age indicates independent damage processes
for each deficit, and negative curvature can indicate sat-
uration, upward curvature indicates an increasing rate of
deficit accumulation with age [25]. Second, average mor-
tality rates increase with increasing F [19]. This increase
underlies the additional clinical predictive value of the
FI, as compared to age alone.
Early quantitative models of human mortality, such
as that of Strehler and Mildvan [26], focused on obtain-
ing the time-dependent mortality directly. More recently,
to capture the upward curvature of F (t), researchers
have introduced explicit time-dependent damage or re-
pair rates in the dynamics of individual health deficits
[6, 7]. To relate deficits with mortality, researchers have
also included explicitly time-dependent dynamics for in-
dividual deficits [18, 27].
Conceptually, individuals are comprised of intercon-
nected, or networked, processes and components. Net-
works underly both healthy function [28] and human dis-
ease [29]. It has been proposed that a network approach
would be appropriate in the study of human aging at var-
ious scales [30]. Indeed, earlier work proposed biochemi-
cal networks at the cellular level [31], and demonstrated
networks of correlations between age-related deficits [32].
Recently, Vural et al have presented a network model of
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Often complex networks are assumed to be scale-free,
where the number of connections (edges) k from each
node has a power law distribution k−α [34]. Such scale-
free networks are heterogeneous – with a few large hubs
that have a large numbers of connections, and many more
nodes that are not well connected. Conversely, nodes in
random networks are homogeneous — all have similar
connectivity. There are indications that networks of hu-
man physiology [28], disease [35], longevity-related pro-
teins [36], and age-related deficits [32] are heterogeneous,
and may be scale-free [28, 36].
In order to better understand how deficit dynamics
can lead to both the observed behavior of F (t) and the
observed mortality, we have developed a stochastic model
of interacting deficits. We represent an individual as an
undirected network of connected deficit nodes, each of
which has two stable states corresponding to healthy or
damaged. In our model, damage and repair rates have
no explicit time-dependence, but do depend on the state
of connected nodes.
For scale-free and random network models, random re-
moval of more than a threshold fraction of nodes leads
to a failure of network connectivity [34, 37]. To deter-
mine animal mortality, the network model of Vural et al.
used a frailty threshold. However an explicit threshold
on F cannot recover the continuously increasing mortal-
ity rates with increasing F that are seen with clinical
human data [19]. To attempt to recover this behavior,
we take mortality to occur when one (or more) of the
most highly connected nodes is damaged, while frailty is
represented by the average damage state of highly con-
nected nodes that are not mortality nodes.
With our model we recover much of the existing frailty
phenomenology, along with a Gompertz-like increase of
mortality with age. This addresses two basic questions.
First, can the upward curvature of F (t) be captured im-
plicitly by interactions between deficits, or must it imply
an explicit age-dependence in, e.g., the damage or repair
rates of individual deficits? Second, can the increase of
mortality with respect to F be captured implicitly by in-
teracting deficits, or must it imply an explicit dynamical
dependence of mortality on F? In both cases, we show
that the behavior can arise naturally and implicitly from
interacting deficits alone.
II. MODEL
For each individual, we consider network nodes i
to represent continuous valued physiological parameters
pi(t), where increasing damage corresponds to increasing
pi, that each follow stochastic over-damped dynamics fol-
lowing an effective potential:
dpi
dt
= −dV
dp
(pi) + σfi + ξi(t) (1)
(a) (b)
repair
damageVi(pi)
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FIG. 1. (color online) (a) Transition rates Γ± between dis-
crete undamaged (di = 0) and damaged (di = 1) states of
a deficit node i are motivated by stochastic dynamics of an
asymmetric double well V˜ (pi) with a continuous damage vari-
able pi, as illustrated. (b) A small network of interactions
(blue lines) between deficit nodes (circles) is illustrated. The
most connected node determines mortality (red circle, “MN”),
while the next most connected nodes determine frailty (yellow
circles, “FN”). (c) Damage (Γ+) and repair (Γ−) rates (per
year), as indicated, for nodes with local frailty fi.
where ξi(t) is Gaussian white noise, σ is the interaction
parameter, and fi is the average damage of all nodes
connected with the ith node (i.e. a local frailty). For
simplicity, we take V (p) to be an asymmetric double-well
potential (see Fig. 1)
V (p) = V0
[
p4
4
− p
3
3
(1 + θ) +
p2
2
θ
]
(2)
with local minima at p = 0 and 1, and an intervening
barrier at θ ≈ 0.5. The interaction term in Eqn. 1 can
also be represented by a tilted effective potential V˜i ≡
V (pi) − σpifi, which then shifts the local minima for
each node and also shifts the intervening barrier θi.
Under the effects of noisy dynamics, individual nodes
will transition randomly between the two local minima
corresponding to healthy states (with pi < θi) and dam-
aged states (with pi > θi), which we discretely label with
deficit indices di = 0 and di = 1, respectively. The local
frailty fi in Eqn. 1 is then defined by fi ≡
∑
dj/ki, where
the sum is over the ki nodes connected with the ith node
so that fi ∈ [0, 1]. We can approximate the transition
rates with Kramer’s limiting rates [38],
Γ±(fi) = Γ0 exp
(
−∆V˜ ±(fi)
D
)
, (3)
where ∆V˜ ± are the barrier heights from the healthy or
damaged sides, corresponding to damage Γ+ and repair
Γ− rates, respectively. The interaction strength σ is kept
small enough so that local minima are well defined even
when fi = 1. Rates depend on the local frailty fi through
Eqn. 1. These transition rates, Γ± vs fi, are illustrated
in Fig. 1(c). The rates show approximately exponential
dependence on the local frailty.
3While the asymmetric double well and stochastic tran-
sitions in Eqns. 1 and 2 are useful to understand our
model, for purposes of computational efficiency we di-
rectly implement the Kramer’s rates in Eqn. 3 for each
node i using exact random sampling of transition times
between healthy and damaged states di = 0 and di = 1
[39]. After each transition of any node, local frailties fj
and transition rates are updated for all connected nodes.
Rather than determining the Kramer’s rate parameters
Γ0 and D directly from Eqns. 1 and 2, we tune them phe-
nomenologically. Γ0 is adjusted so that our model results
agree with the most likely death age in human mortality
statistics, which is 87.5 years [40]. This amounts to a
rescaling of time, or an overall rescaling of either side of
Eqn. 1. V0/D is adjusted to obtain a fixed asymmetry
ratio of damage to repair rates, R ≡ Γ+(0)/Γ−(0). This
amounts to rescaling the noise amplitude ξ and/or the
potential V0.
Each individual is represented by N nodes, which are
all initially undamaged at age t = 0. The undirected
network of interactions is generated for each individual
with a characteristic scale-free exponent α = 3 and aver-
age connectivity 〈k〉 [34]. For comparison (see appendix),
random networks with N nodes and average connectivity
〈k〉 were generated by connecting N〈k〉/2 edges between
randomly selected pairs of nodes. At least 10000 indi-
viduals are sampled for each parameter set in the paper.
Unless otherwise noted, we use standard model param-
eters of N = 800 nodes, average connectivity 〈k〉 = 10,
potential shape θ = 0.48, and scaled interaction strength
σ˜ = σ/D = 25, and asymmetry ratio R = 10. The de-
pendence of our results on these parameter choices are
explored below.
In most of this paper, and unless otherwise noted, we
have defined mortality to occur when the most connected
node is damaged. This is an attractively simple mortality
condition. We have also explored using more than one of
the most connected nodes to define mortality (see Fig. 5
below, or Figs. 7 and 8). When there is degeneracy, we
choose mortality nodes at random from among the most
connected. We define the frailty index to be
Fn(t) =
∑
j
dj(t)/n, (4)
where the sum is over the n most highly connected non-
mortality nodes. Since each dj ∈ {0, 1}, we have F ∈
[0, 1]. Unless otherwise noted, we take n = 30. Fn is a
diagnostic measure, and is not directly involved in either
damage or repair of individual nodes or in mortality. This
allows us to critically examine the relationship between
F (t) and mortality without explicit overlap between the
two. Our focus in this paper is on older individuals, above
the age of 50.
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FIG. 2. (color online) The mortality rate, or chance of
death per year, vs age from 2010 U.S. population life ta-
bles [40] is shown as a solid red line. Our model mortality
rates are shown with filled black circles, using default pa-
rameter values. We have qualitative agreement for ages
above 50. We also show, as indicated by the legend, mor-
tality rates for four quintiles of frailty index (F30) vs age.
In the inset we show model mortality rates vs F30.
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FIG. 3. (color online) The frailty index F vs age deter-
mined from Canadian population data [6] is shown with
red circles and a red line. Our model results Fn are also
shown, with n = 30 and n = 799 by black and small green
circles, respectively.
III. RESULTS
The solid red line in Fig. 2 shows United States mortal-
ity rate statistics (chance of death per year) vs. age [40].
The approximately exponential growth of mortality after
age 50 is Gompertz’s law [1]. Our model mortality curve,
with default parameters, is shown with filled black circles.
After age 50, our model exhibits a Gompertz-like increase
in mortality rate. Our model includes no developmental
details, and so misses the peak of early-childhood mortal-
ity. In the inset we show that the mortality rate monoton-
4ically increases with F30. The increase is approximately
exponential, as reported for clinical data [19].
In Fig. 3 we show the frailty index vs age, as deter-
mined from the Canadian National Public Health Survey
(NPHS) from 1994-2011 [6] (red circles with red line).
Notable is a significant upward curvature after age 60.
Also shown are model Fn, for n = 30 or 799, (black or
small green circles, respectively) with similar upward cur-
vature at later ages, due to our non-zero interaction σ.
Our model starts at t = 0 with all di = 0, so that F = 0.
We see that Fn is slightly above the population F data,
though the agreement becomes better at smaller n. The
choice of the number of deficits n included in the diag-
nostic frailty Fn has no influence on the model dynamics.
However, increasing n includes more nodes with lower
connectivity – and simultaneously decreases the weight
given to highly connected nodes. The dependence of Fn
on n therefore indicates that highly connected nodes are
somewhat protected from accelerated damage due to in-
teractions.
The deficit nodes included in Fn exclude the mortal-
ity node. The coloured points of Fig. 2, as indicated by
the legend, shows the model mortality rates vs. age for
individuals grouped by quartiles of the frailty index. At
every age, mortality is strongly affected by F – as also
shown in the inset. Conversely, at a given F the mor-
tality rates are only relatively weakly dependent on age.
Much (though not all) of the weak age dependence within
the quartiles results from variations of F within the quar-
tile. At younger ages (. 60 years), the mortality rates of
the lowest quartile are nearly identical to the population
average – reflecting the low frailties at those ages.
We show the distribution P (F ) for different ages in
more detail in Fig. 4. We can see that both the av-
erage and peak F increases with age. The shape of
the distribution P (F ) also changes with age, evolving
from a right-skewed distribution at young ages towards a
more symmetrical distribution for older sub-populations
[13, 16]. On the left, in Fig. 4 (a), we find this pattern
with our model data. The distribution does not become
left-skewed, even though we must have F ≤ 1, since mor-
tality typically removes individuals as they reach higher
F . On the right, in Fig. 4 (b), we show Chinese popula-
tion data for the same age ranges [13]. While the qualita-
tive patterns are the same, the Chinese data population
data is shifted towards lower frailties. Notably, the model
exhibits all values of F ∈ [0, 1] while the population data
shows an apparent maximal value of Fmax ≈ 0.7 − 0.8.
Other population studies have also reported a maximal
Fmax ≈ 0.7− 0.8 [41].
Fig. 5 shows the results of having mortality result from
the damage of any of the top 1, 2, or 4 connected nodes.
Note that using one node is our standard mortality rule
used elsewhere in the paper. The peak of the death-age
distribution is rescaled to 87.5 years in each case, and
this leads to continued agreement of mortality rates at
older ages. With this logical-“OR” with multiple mor-
tality nodes, we see in (a) that the mortality at younger
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FIG. 4. (color online) Distribution P (F ) for different age
ranges, as indicated in the legend. (a) model results, using
F30, (b) Chinese population data from Gu et al [13].
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FIG. 5. (color online) Model results with modified mor-
tality that occurs when any of the top one, two, or four
nodes are damaged (black circles, green triangles, and yel-
low squares respectively). The parameters are otherwise
the same as our default parameterization. Red lines cor-
respond to population data. (a) Mortality rate vs age, (b)
F30 vs age, (c) model data frailty distribution, P (F30) vs
F30, for age cohorts between 65-69 years (dashed lines)
and between 100-105 years (solid lines).
ages increases. However, in (b) the agreement with F vs
age is improved. We also see in (c) that an approximate
Fmax ≈ 0.7− 0.8 emerges when the top 4 nodes are used
for mortality. Essentially, it becomes increasingly un-
likely to have more than one of the top (mortality) nodes
undamaged and yet to still have large F . We note that
in our model there is no strict frailty maximum, and so
multiple-node “OR” may not be the underlying cause of
the population frailty maximum. Clearly the mortality
condition is important, and is a sensitive control of qual-
itative model behavior. [More data with a multi-node
logical-“OR” mortality is shown in the appendix in Fig. 7
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FIG. 6. (color online) Damage (Γ+) and repair (Γ−)
rates vs age, averaged over undamaged or damaged frailty
nodes, respectively, corresponding to F30 or F799 as indi-
cated. All rates are per year. The inset shows the same
rates vs F30.
while the complementary multi-node logical “AND” mor-
tality is explored in Fig. 8.]
Fig. 6 shows our model damage (Γ+) and repair (Γ−)
rates vs. age, where rates are per year. Increasing age
monotonically increases the damage rate, and decreases
the repair rate. To obtain Γ± vs age, we have averaged
the local rates over the indicated frailty nodes for the
surviving population. The inset shows the same rates vs.
F30. They are consistent with the similar trends in Γ±
vs local frailty fi shown in Fig. 1 (c), together with the
average increase of F with age.
IV. DISCUSSION
The frailty index F is a quantitative measure of in-
dividual aging that is as informative as chronological
age in predicting health outcomes, including mortality.
The FI is defined as the fraction of damaged health-
related deficits. Given the increasing health burden on
our burgeoning elderly population, it is important to bet-
ter understand the observed quantitative dynamics of the
frailty index. To do this, we have developed a stochastic
model of damage and repair of interacting deficits. The
stochasticity of F is important, and we have qualitatively
recovered the observed broadening of the distribution
P (F ) with age (see Fig. 4). Stochasticity can, in princi-
ple, arise from either stochastic damage or stochastic re-
pair – or both. We have found that a significant amount
of explicit deficit repair is consistent with observed age-
dependent mortality and F (see appendix Fig. 14).
We have addressed our two key questions. First, can
the observed upward curvature of F vs age be obtained
with time-independent interactions between deficits, or
must explicitly time-dependent damage rates be invoked?
We have shown (see Fig. 3) that time-independent inter-
actions (σ˜) alone are sufficient. Second, can we recover
the observed connection between F and mortality with-
out building F directly into model mortality? We have
shown that this is indeed possible (see Fig. 2), since the
(highly connected) deficits we have used for mortality
have no overlap with the (less connected) deficits that
we have used for our frailty measure Fn.
Due to deficit interactions, our model repair rates are
age dependent (see Fig. 6). While strong age-dependent
slowing in human wound-healing rates have been re-
ported since the seminal work of Lecomte du Nou¨y [42],
more recent emphasis has been on the proximal mech-
anisms controlling these rates – resulting in questions
about how or whether to attribute slowed healing to age
per se [43]. Nevertheless, age-related slowing of wound-
healing is also reported in e.g. mice [44]. Echoing this,
bone fracture repair is impaired in older rats [45], though
recent emphasis has been on detailed mechanisms behind
this slowing [46]. Indeed, there are many age-related
changes that could be considered even at the cellular level
[47]. Our model provides a coarse-grained picture of in-
teractions between deficits, and indicates that age-related
slowing may be driven by frailty-related slowing. Given
the large variability of F at a given age (see Fig. 4), we
conclude that F is important to control for when assess-
ing age-dependent repair rates.
It is attractive to think that highly connected model
deficits correspond to clinically-accessible high-level
physiological states. Indeed, we use our most connected
node to indicate mortality and reserve the next-most con-
nected nodes for Fn. However, there is no direct equiva-
lence between model deficits and any specific physiolog-
ical deficits. Indeed, we may best think of our model
deficits as combinations of physiological measures. Sim-
ilarly, we might think of conveniently accessible clinical
deficits (see e.g. [4]) as reflecting combinations of cellular,
organ, and systems-level mechanisms (see e.g. [14]). If
so, the effective connectivity of individual clinical deficits
may be difficult to directly assess.
In the appendix, we have systematically varied each of
our key model parameters to see how they affect mortal-
ity, F and deficit transition rates. The default param-
eters used in our paper were found to give reasonable
qualitative agreement with current data [48]. We have
illustrated how including more highly connected nodes
in our mortality rules can improve F evolution and dis-
tribution (see Fig. 5) – albeit at the expense of further
overestimating mortality rates at younger ages. This was
done by triggering mortality if any of multiple mortality
nodes are damaged. Complementing this, in Fig. 8 we
have explored triggering mortality only if all of multiple
mortality nodes are damaged. In that case, we can get
better agreement with mortality rates but worse agree-
ment with F behavior. The sensitivity of our model re-
sults to mortality rules is promising since it will allow us
to better explore the connection between model deficits
and mortality and so between clinical deficits and human
mortality.
6While we have found that both the average and the
distribution of connectivities affect our model behavior
when other parameters are kept fixed (see Fig. 9 and 11),
we caution that we have not exhaustively searched pa-
rameter space and so cannot rule out alternative topolo-
gies [48]. We have also not explored differences between
directed (see e.g. [33]) and non-directed network links.
In this work we have only used non-directed links, and
have predominately considered scale-free networks. In
future work, we will use our model to develop new diag-
nostics that are more sensitive to network topologies and
apply them to clinical data in order to better characterize
effective interaction networks of clinical deficits.
The emerging prospects of large quantities of labora-
tory or biomarker data [14], as well as tracked health
data [49], usable for assessing frailty present the ques-
tion of how to rationally incorporate new data when it is
available to best contribute towards health assessment.
In future work, we will use our model to learn how to
construct a better F that is more predictive of individ-
ual mortality. Such a frailty measure may include aspects
of individual frailty trajectories, but also an optimized
compromise between number and quality of deficits. Our
computational model will allow us to start this develop-
ment with high-quality model data, before we test our
insights against current and emerging clinical data.
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Appendix: Parameter scan
In this appendix we systematically explore the effects
of varying our model parameters. We show the effects of
varying parameters around our default parameter values
or mortality rules. For each figure, we show (a) mortality
rate vs age for indicated parameter values, with the solid
red line indicating 2010 U.S. population data [40], (b)
F vs age for indicated parameter values, where the red
circles indicate Canadian population data [6], (c) frailty
distributions P (F ) at ages 40−49 years and 90−99 years
for indicated parameter values, and (d) transition rates
Γ± vs age for indicated parameter values.
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FIG. 7. We have explored the effect of multiple mortality
nodes (one, two, or 4 nodes with black circles, green squares,
or pink triangles, respectively), where mortality occurs when
any of the mortality nodes are damaged (like a logical “OR”).
This was presented in a more compressed format in Fig. 5.
One mortality node (black circles) corresponds to our default
mortality rule. (a) mortality rate vs age, (b) F vs age, (c)
frailty index distribution P (F ) for young (ages 40− 49 years)
and old (ages 90− 99 years) cohorts, and (d) transition rates
Γ± vs age, averaged over the F30 nodes. We see that using
more nodes in “OR” mortality leads to higher mortality at
earlier ages, but improves F vs age and also introduces a gap
at larger F .
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FIG. 8. We have explored the effect of multiple mortality
nodes (one, two, or 4 nodes with black circles, green squares,
or pink triangles, respectively), where mortality occurs when
all of the mortality nodes are damaged (a logical “AND”).
One mortality node (black circles) corresponds to our default
mortality rule. We see that using more nodes in “AND” mor-
tality leads to lower mortality at earlier ages, but at the ex-
pense of worse F vs age.
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FIG. 9. We have varied the average degree 〈k〉 characterizing
the scale-free network, with 〈k〉 = 2 (green squares), 〈k〉 = 10
(black circles and our default parameterization), and 〈k〉 = 20
(pink triangles). (a) mortality rate vs age, (b) F vs age, (c)
frailty index distribution P (F ) for young (ages 40− 49 years)
and old (ages 90− 99 years) cohorts, and (d) transition rates
Γ± vs age, averaged over the F30 nodes.
8 0.0001
 0.001
 0.01
 0.1
 1
 0  20  40  60  80  100
M
o r
t a
l i t
y  
R a
t e
Age (years)
(a)
Data
N= 800
N=400
N=1600
 0
 0.1
 0.2
 0.3
 0.4
 0.5
 0.6
 0  10  20  30  40  50  60  70  80  90  100
F r
a i
l t y
 I n
d e
x
Age (years)
(b)
Data
N=800
N=400
N=1600
100
101
101
101
101
101
 0  0.2  0.4  0.6  0.8  1
F r
e q
u e
n c
y  
%
Frailty Index
(c)
N=400:
Age 40-49
Age 90-99
N=800:
Age 40-49
Age 90-99
N=1600:
Age 40-49
Age 90-99
10-6
10-4
10-2
100
102
104
 0  20  40  60  80  100
T r
a n
s i t
i o
n  
R a
t e
s
Age (years)
(d)
N=400:
Damage
Repair
N=800:
Damage
Repair
N=1600:
Damage
Repair
FIG. 10. We have varied the number of nodes N , with
N = 800 (black circles, our default value), N = 200 (green
squares), and N = 1600 (pink triangles). (a) mortality rate
vs age, (b) F vs age, (c) frailty index distribution P (F ) for
young (ages 40 − 49 years) and old (ages 90 − 99 years) co-
horts, and (d) transition rates Γ± vs age, averaged over the
F30 nodes. We see that with sufficiently many nodes, the
results are approximately independent of N .
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FIG. 11. We have done some exploration of different network
models. Here we show how random and scale-free networks
(both with average degree 20) compare with a fully connected
networks (with degree equal to N − 1, since nodes don’t con-
nect to themselves). (a) mortality rate vs age, (b) F vs age,
(c) frailty index distribution P (F ) for young (ages 40 − 49
years) and old (ages 90−99 years) cohorts, and (d) transition
rates Γ± vs age, averaged over the F30 nodes. We see that
while all networks are similar, there are apparent differences
in the behavior of F vs age for the scale-free network.
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FIG. 12. We have varied the scaled interaction σ˜, with σ˜ = 20
(green squares), σ˜ = 25 (the default value, black circles), and
σ˜ = 30 (pink triangles). (a) mortality rate vs age, (b) F
vs age, (c) frailty index distribution P (F ) for young (ages
40 − 49 years) and old (ages 90 − 99 years) cohorts, and (d)
transition rates Γ± vs age, averaged over the F30 nodes. We
see that the upward curvature of the F vs age plot increases
with increasing σ˜.
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FIG. 13. We have varied the shape of the potential, θ, with
θ = 0.48 (default value, black circles), θ = 0.485 (green
squares), and θ = 0.495 (pink triangles). We note that θ = 0.5
corresponds to a symmetric potential, so does not allow asym-
metric transition rates at fi = 0. (a) mortality rate vs age,
(b) F vs age, (c) frailty index distribution P (F ) for young
(ages 40− 49 years) and old (ages 90− 99 years) cohorts, and
(d) transition rates Γ± vs age, averaged over the F30 nodes.
We see that θ does not strongly change our results.
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FIG. 14. We have varied the initial ratio of damage to re-
pair rates R ≡ Γ+(0)/Γ−(0), with R = 5 (green triangles),
R = 10 (our default value, black circles), and R = 15 (pink
triangles). (a) mortality rate vs age, (b) F vs age, (c) frailty
index distribution P (F ) for young (ages 40 − 49 years) and
old (ages 90− 99 years) cohorts, and (d) transition rates Γ±
vs age, averaged over the F30 nodes. We see that R does not
strongly change our results.
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